HemoGenyx Pharmaceuticals Plc (HOPHF)

2.33 0.00 (0.00%) USD  |  OTCM  |  Oct 15, 16:00
More

HemoGenyx Pharmaceuticals Research and Development Expense (Quarterly)

Research and Development Expense (Quarterly) Chart

Historical Research and Development Expense (Quarterly) Data

View and export this data back to . Start Trial.
Date Value

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Silence Therapeutics Plc 8.297M
Biodexa Pharmaceuticals Plc --
NuCana Plc 3.020M
Mereo BioPharma Group Plc 1.811M
Compass Pathways Plc 29.23M